Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
36,309,263
-
Shares change
-
+3,035,780
-
Total reported value, excl. options
-
$1,175,380,829
-
Value change
-
+$117,821,671
-
Put/Call ratio
-
84.5%
-
Number of buys
-
77
-
Number of sells
-
-85
-
Price
-
$32.40
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2015
217 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2015.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,309,263 shares
of 80,437,135 outstanding shares and own 45.1% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3,167,021 shares), VANGUARD GROUP INC (2,046,376 shares), FMR LLC (1,930,027 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1,872,220 shares), WADDELL & REED FINANCIAL INC (1,854,184 shares), Sectoral Asset Management Inc (1,586,258 shares), STATE STREET CORP (1,521,909 shares), WELLS FARGO & COMPANY/MN (1,466,898 shares), PUTNAM INVESTMENTS LLC (1,449,289 shares), and BB BIOTECH AG (1,302,912 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.